...
机译:对CD34 +造血干细胞和祖细胞的基于CRISPR / CAS9-AAV6基因组的全局转录反应
Department of Pediatrics Stanford University;
Department of Pediatrics Stanford University;
Agilent Technologies;
Agilent Technologies;
Agilent Technologies;
Department of Pediatrics Stanford University;
Department of Pediatrics Stanford University;
Department of Pediatrics Stanford University;
Department of Pediatrics Stanford University;
Agilent Technologies;
Department of Pediatrics Stanford University;
Department of Pediatrics Stanford University;
Institute for Nanotechnology and Advanced Materials The Mina and Everard Goodman Faculty of Life;
Agilent Technologies;
Department of Pediatrics Stanford University;
genome editing; RNA expression analysis; hematopoietic stem cells;
机译:对CD34 +造血干细胞和祖细胞的基于CRISPR / CAS9-AAV6基因组的全局转录反应
机译:CRISPR / Cas9对小鼠和人类造血祖细胞的高效基因组编辑
机译:用CRISPR-CAS9系统在造血干/祖细胞中进行高效基因编辑
机译:通过使用CRISPR-CAS9基因组编辑靶向转录因子TBR1和TBR2来提高人类神经干细胞分化的效率
机译:β-肾上腺素能受体介导的造血干细胞和祖细胞中的转录失调导致多发性骨髓瘤患者的骨髓红细胞抑制 - 以外的研究
机译:CD34 +造血干细胞和祖细胞中基于CRISPR / Cas9-AAV6的基因组编辑的全球转录反应。
机译:通过CRIspR / Cas9高效率地编辑小鼠和人类造血祖细胞的基因组